|
|
Programme
Day 2: Saturday, 5 November 2005
Hall A (Symposia Hall, NASC Complex)
|
VECTOR BIOLOGY & CONTROL |
|||
|
Chairperson: PK Rajagopalan Rapporteur: PK Srivastava |
|||
|
9:30-9:55 |
INVITED SPEAKER |
||
|
|
R Maharaj, South Africa |
|
Successful Malaria Vector Control Using Indoor Residual Spraying In Southern Africa |
|
9:55-11:00 |
FREE PAPERS |
||
|
|
DR Roberts, USA |
|
The chemical actions of DDT and other insecticides recommended for indoor residual spray programs |
|
|
GRA Okogun, Nigeria |
|
Life table analysis of anopheles malaria vectors: Generational mortality as tool in mosquito vector abundance and control studies |
|
|
N Surendran, Sri Lanka |
|
Some bionomics of sibling species B and E in the Anopheles culicifacies species complex in Sri Lanka |
|
|
Nanda N, India |
|
Anopheles fluviatilis species S-related malaria in hyper endemic districts of Orissa state, India |
|
|
Singhal V, India |
|
Industries point of view for malaria control in India (abstract not received) |
|
|
Dutta.GDP, India |
|
Field evaluation of Pyriproxifen (0.5G) against larvae of mosquito vectors in the district Shahjahanpur, Uttar Pradesh, India |
|
11:00-11:30 |
TEA BREAK |
||
|
11:30-11:55 |
INVITED SPEAKER |
||
|
|
DN Deobhagkar, India |
|
Can high ambient temperature modulate gut microflora and vectoral competence of mosquito? |
|
11:55-13:00 |
FREE PAPERS |
||
|
|
H Vatandoost, Iran |
|
Ecology of Anopheles fluviatilis James in a malarious area, Bandar Abbas, Hormozgan province, southern Iran |
|
|
K Raghavendra, India |
|
Insecticide resistance in Anopheles culicifacies : Options for control and management |
|
|
K Viswanathan, India |
|
Role of household insecticides in mosquito control |
|
|
SK Gakhar, India |
|
Development of mosquito transgenesis in Anopheles stephensi to control malaria |
|
|
Pandey BK, India |
|
Effect of difluorobenzoron against mosquito species of Anopheles, Ades and Culex (abstract not received) |
|
|
Ghosh SK, India |
|
Planning of vector control programme in Bangalore City |
|
13:00-14:30 |
LUNCH BREAK AND POSTER VIEWING |
||
|
MOLECULAR BIOLOGY OF MALARIA PARASITES AND VECTORS |
|||
|
Chairperson: D.Deobagkar Rapporteur: Arun Sharma |
|||
|
14:30-15:10 |
|
||
|
|
Jane M Carlton, USA |
|
The Plasmodium vivax Genome Sequence and Comparative Analysis with Plasmodium falciparum |
|
|
YD Sharma, India |
|
Molecular epidemiology of drug resistant malaria |
|
15:10-16:00 |
FREE PAPERS |
|
|
|
|
S Chaubey, India |
|
Translation within the apicoplast of Plasmodium falciparum is targeted by thiostrepton |
|
|
AA Eskandarian, Iran |
|
Molecular assessment of Plasmodium falciparum resistance to antifolate drugs in endemic malarious areas in Iran |
|
|
S Mishra, India |
|
An efficient detection of chloroquine resistance marker in pfCRT gene of Plasmodium falciparum from complicated Malaria Samples By PCR-SSCP analysis |
|
|
A Mohanty, India |
|
Molecular study of Anopheles fluviatilis species complex in different geographical regions of Orissa |
|
|
MR Ranjit, India |
|
The PfCRT (K76T) point mutation favours clone multiplicity and disease severity in Plasmodium falciparum infection |
|
16:00-16:30 |
TEA BREAK |
||
|
16:30-17:15 |
PLENARY SESSION |
||
|
Chairperson: S.Pattanayak Rapporteur: RC Dhiman |
|||
|
|
G Padmanabhan, India |
|
Quest for drugs and drug targets against malaria- Old and New |
Hall B (Committee Room I, NASC Complex)
|
CHEMOTHERAPY, DRUG RESISTANCE & CLINICAL MANAGEMENT |
|||
|
Chairperson: N Kshirsagar Rapporteur: AM Reetha |
|||
|
09:30-09:55 |
INVITED SPEAKER |
||
|
|
DH Hamer, USA |
|
Vitamin A, Zinc, and Paediatric Malaria |
|
09:55-11:00 |
FREE PAPERS |
|
|
|
|
A Das, India |
|
Severe malaria caused by Plasmodium vivax with Type 1 CSP repeats |
|
|
GP Chhotray, India |
|
Distribution of P falciparum genotypes in clinically mild and severe malaria cases in orissa, India |
|
|
AA Joshi, India |
|
Rational design and synthesis of 5-heteroarylaminopyrimidoquinolines as potential antimalarials |
|
|
PK Mandal, India |
|
Efficacy of arteether in chloroquine resistant falciparum malaria in eastern India |
|
|
DK Kochar, India |
|
A comparative study of regression of jaundice in malaria and acute viral hepatitis |
|
|
LK Das, India |
|
Clinical manifestations of severe forms of P falciparum malaria in Koraput district of Orissa state, India |
|
11:00-11:30 |
TEA BREAK |
||
|
CHEMOTHERAPY, DRUG RESISTANCE & CLINICAL MANAGEMENT |
|||
|
11:30-12:10 |
INVITED SPEAKERS |
||
|
|
K Yeboah-Antwi, USA |
|
Iron, anaemia and malaria |
|
|
SK Jain, India |
|
Artemisinin: Biotechnological approaches for enhanced biosynthesis and molecular mechanism of its action |
|
12:10-13:00 |
FREE PAPERS |
||
|
|
BN Mohapatra, India |
|
High Serum Triglyceride (TG) level A predictor of severity in falciparum malaria |
|
|
SK Mishra, India |
|
A randomised comparison of artesunate versus quinine in the treatment of severe falciparum malaria |
|
|
MK Mohapatra, India |
|
The natural history and assessment of severity of organ dysfunction in complicated falciparum malaria |
|
|
A Pareek, India |
|
Efficacy and safety of b-arteether and a/b-arteether injections in acute falciparum malaria: a double blind, randomised multicentric clinical trial |
|
|
I van den Broek, UK |
|
Efficacy of combination therapies for uncomplicated Plasmodium falciparum malaria in the Chittagong Hilltracts, Bangladesh |
|
13:00-14:30 |
LUNCH BREAK AND POSTER VIEWING |
||
|
14:30-15:10 |
INVITED SPEAKERS |
||
|
|
PV Venugopal, Switzerland |
|
R & D in antimalarials: Past, present and future (abstract not received) |
|
|
N Kshirsagar, India |
|
Drug resistance (abstract not received) |
|
15:10-16:00 |
FREE PAPERS |
||
|
|
S Parikh, USA |
|
HIV protease inhibitors target the malaria parasite, Plasmodium falciparum |
|
|
KP Pattnaik, India |
|
Study of comparative efficacy and safety of quinine or artesunate alone or their combination in severe falciparum malaria |
|
|
RS Rajakaruna, Sri Lanka |
|
Role of private drug vendors on malaria treatment in Sri Lanka |
|
|
SK Sharma, India |
|
Assessment of therapeutic response of chloroquine and sulfa-pyrimethamine in uncomplicated P falciparum malaria cases in Sundargarh and Mayurbhanj districts of Orissa |
|
|
P Hamade, UK |
|
Implementing artesunate combination treatment for uncomplicated falciparum malaria in Assam state |
|
16:00-16:30 |
TEA BREAK |
||
Hall C (Committee Room II, NASC Complex)
|
IMMUNOLOGY & VACCINE DEVELOPMENT |
|||
|
Chairperson: RC Mahajan Rapporteur: SK Sharma |
|||
|
09:30-09:55 |
INVITED SPEAKER |
||
|
|
RA Vishwakarma, India |
|
New and convergent chemical synthesis of full-length GPI-anchor of Plasmodium falciparum |
|
09:55-11:00 |
FREE PAPERS |
||
|
|
GK Jarori, India |
|
P falciparum Enolase |
|
|
L R้nia, France |
|
Cross-stage immunity induced by vaccination with blood parasite under chloroquine treatment |
|
|
PV Lalitha, India |
|
Production and immune analysis of Domain I+II of AMA-1 ectodomain from Indian P falciparum isolates |
|
|
WR Weiss, USA |
|
Pre-erythrocytic immunity in Primates: CD8+ T cells play a prominent role in protecting rhesus monkeys against infection by Plasmodium knowlesi sporozoites |
|
|
DV Desai, India |
|
Prediction of Promiscuous MHC binding Antigenic Peptides of some Malarial Proteins |
|
11:00-11:30 |
TEA BREAK |
||
|
EPIDEMIOLOGY |
|||
|
Chairperson: DR Roberts Rapporteur: RK Dasgupta |
|||